SpineZone Raises $12M in Series A Funding


SpineZone, a San Diego, CA-based provider of non-operative, personalized treatment for musculoskeletal conditions, closed a Series A funding round of $12m.

The round was led by Polaris Partners and Providence Ventures, with participation from Martin Ventures.

The company intends to use the funds to enter into new markets and strategic partnerships with health systems, health plans, employers, and other organizations, along with expanding its clinic presence.

Led by Kian Raiszadeh, M.D., co-founder and CEO, and and Kamshad Raiszadeh, M.D., co-founder and Chief Medical Officer, SpineZone uses its online platform, data-driven personalized treatment programs, and in-person clinics to treat back and neck pain, while minimizing the need for prescription drugs, injections, and surgeries. Patients receive personalized guidance and at-home exercises from the online platform, and have the option to receive in-person treatment at SpineZone’s local clinics in Southern California.

The program connects patients with a customized online platform that they can access via smartphone or laptop; patients are evaluated for their overall level of pain and possible related complications and risk factors, and then are assigned a series of exercises that they can do at home, guided by the app and with constant communication with SpineZone’s team of physicians, physician assistants, and physical therapist “Coaches.”

The company receives patients via referrals from primary care physicians and strategic partnerships with health plans, health systems, and employers. It currently has 1 million lives under management, and has partnerships with major health systems such as Sharp HealthCare, Scripps, Providence, and national health plans such as Anthem.